Free Trial

Stock Analyst Downgrades

Explore the most recent stock downgrades, analyst downgrades, and changes to stock analyst ratings in this continuously updated list of analyst recommendations. This page captures each newly issued downgrade, including adjustments to stock ratings, price targets, and analyst coverage, making it easy to follow all the latest downgrades and rating changes.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Autohome Inc. stock logo
ATHM
Autohome
Downgraded by$17.77
-7.5%
$17.30BuyHold
Bird Construction Inc. stock logo
BDT
Bird Construction
Downgraded by C$51.09
+2.5%
C$52.00 ➝ C$55.00OutperformMarket Perform
Camden Property Trust stock logo
CPT
Camden Property Trust
Downgraded by$104.01
-1.3%
$113.00 ➝ $95.00Sector PerformSector Underperform
Doximity, Inc. stock logo
DOCS
Doximity
Downgraded by$17.94
-23.3%
OverweightSector Weight
Doximity, Inc. stock logo
DOCS
Doximity
Downgraded by$17.94
-23.3%
$51.00 ➝ $19.00BuyHold
Doximity, Inc. stock logo
DOCS
Doximity
Downgraded by$17.94
-23.3%
BuyNeutral
Amdocs Limited stock logo
DOX
Amdocs
Downgraded by $61.93
+3.3%
Sell
Flutter Entertainment plc stock logo
FLTR
Flutter Entertainment
Downgraded by GBX 6,944
-0.5%
£127 ➝ £115Overweight
Jbs N.V. stock logo
JBS
JBS
Downgraded by$14.02
-4.6%
$20.50 ➝ $18.50OverweightNeutral
KT Corporation stock logo
KT
KT
Downgraded by $19.71
-3.5%
$23.08BuyNeutral
Read this or regret it forever (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
MDxHealth SA stock logo
MDXH
MDxHealth
Downgraded by $0.98
-49.5%
OutperformMarket Perform
Bandai Namco Holdings Inc. - Unsponsored ADR stock logo
NCBDY
Bandai Namco
Downgraded by C$11.55
-3.8%
Sell
NetApp, Inc. stock logo
NTAP
NetApp
Downgraded by $119.93
+1.1%
NeutralMixed
Everpure, Inc. stock logo
P
Everpure
Downgraded by$83.56
-1.0%
$90.00BuyNeutral
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
Downgraded by$45.95
-11.3%
OutperformMarket Perform
Pollard Banknote Limited stock logo
PBL
Pollard Banknote
Downgraded by C$15.96
-7.6%
C$29.00 ➝ C$21.50OutperformMarket Perform
Power Co. of Canada stock logo
POW
Power Co. of Canada
Downgraded by C$80.72
+1.9%
C$74.00 ➝ C$84.00BuyHold
Microlise Group plc stock logo
SAAS
Microlise Group
Downgraded by GBX 42.50
-26.7%
GBX 191 ➝ GBX 166Buy
Starbucks Corporation stock logo
SBUX
Starbucks
Downgraded by$106.40
+0.4%
Neutral
Starbucks Corporation stock logo
SBUX
Starbucks
Downgraded by $106.40
+0.4%
Neutral
Starbucks Corporation stock logo
SBUX
Starbucks
Downgraded by$106.40
+0.4%
Sector PerformPositive
Starbucks Corporation stock logo
SBUX
Starbucks
Downgraded by$106.40
+0.4%
BuyNeutral
Starbucks Corporation stock logo
SBUX
Starbucks
Downgraded by $106.40
+0.4%
Market PerformUnderperform
Solstice Advanced Mat stock logo
SOLS
Solstice Advanced Mat
Downgraded by $86.81
-2.0%
$90.00BuyHold
Solventum Corporation stock logo
SOLV
Solventum
Downgraded by$74.40
0.0%
$50.00BuyNeutral
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
Downgraded by$24.87
-2.5%
$18.00 ➝ $27.00BuyHold
Wix.com Ltd. stock logo
WIX
Wix.com
Downgraded by$52.71
-4.7%
$105.00 ➝ $66.00BuyNeutral
Wix.com Ltd. stock logo
WIX
Wix.com
Downgraded by$52.71
-4.7%
$90.00 ➝ $60.00OutperformSector Perform
Wix.com Ltd. stock logo
WIX
Wix.com
Downgraded by $52.71
-4.7%
$54.00OverweightEqual Weight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:19 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.